Upgrade to SI Premium - Free Trial

Zimmer Biomet (ZBH) PT Raised to $153 at Needham & Company; Buy on Weakness

April 27, 2017 1:46 PM
Needham & Company raised its price target on Zimmer Biomet (NYSE: ZBH) to $153.00 (from $151.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles